The Consortium

The CoroNAb consortium comprises researchers from:

  • Karolinska Institutet (Sweden)

  • Statens Serum Institut (Denmark)

  • ETH Zurich (Switzerland)

  • Imperial College London (The United Kingdom)

CoroNAb is engaged in research aiming to understand SARS-CoV-2 and COVID-19.


  • To investigate protein subunit immunization strategies that elicit antibodies that neutralize SARS-CoV-2.

  • To identify and study, in detail, the antibodies that are elicited by such immunization strategies.

  • To identify and characterize alpaca single-domain antibodies that can bind to and neutralize SARS-CoV-2.

  • To investigate new technologies for antibody optimization.

  • To model pandemic dynamics and the potential effects of interventions.